Previous Article | Next Article 
Infect Immun, March 1998, p. 1208-1215, Vol. 66, No. 3
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Defective Nitric Oxide Effector Functions Lead to
Extreme Susceptibility of Trypanosoma cruzi-Infected Mice
Deficient in Gamma Interferon Receptor or Inducible Nitric Oxide
Synthase
Christoph
Hölscher,1,2
Gabriele
Köhler,3
Uwe
Müller,1,2
Horst
Mossmann,1
Günter A.
Schaub,2 and
Frank
Brombacher1,4,*
Max Planck Institute for
Immunobiology1 and
Department of
Pathology, University of Freiburg,3 Freiburg,
and
Department of Special Zoology and Parasitology,
Ruhr-University-Bochum, Bochum,2 Germany,
and
Department of Immunology, University of Cape Town, Cape
Town, South Africa4
Received 23 September 1997/Returned for modification 24 November
1997/Accepted 19 December 1997
 |
ABSTRACT |
Trypanosoma cruzi, the causative agent of Chagas'
disease, induces an innate and adaptive host immune response during the acute phase of infection. These responses were analyzed by comparing mouse lines deficient for the gamma interferon (IFN-
) receptor (IFN-
R
/
) or deficient for inducible nitric oxide
synthase (iNOS
/
). Both lines were highly susceptible,
with similar and dramatically increased parasite burdens and severe
histopathology and were incapable of surviving even very low doses,
exhibiting similar mortality kinetics. This pathophysiological
correlation has a common cause, since both mutant mouse strains were
unable to respond to infection by producing nitric oxide (NO) with the
consequence that mutant macrophages had impaired trypanocidal
activities. These in vivo and subsequent in vitro studies further
demonstrated that an IFN-
-dependent pathway of iNOS induction is
crucial for efficient NO production and mandatory for resisting acute
infection with T. cruzi. Despite this defect, both mutant
mouse strains had a rather normal proinflammatory cytokine response
(interleukin-12 [IL-12], IFN-
, IL-6), with the exception of an
impaired tumor necrosis factor alpha and IL-1
response in
IFN-
R
/
mice, demonstrating that only the latter two
cytokines are dependent on IFN-
activation. Moreover, polarization
of T cells in type 1 and type 2 T-helper (Th1/Th2) and cytotoxic T
(Tc1/Tc2) cells as well as T. cruzi-specific antibody
responses were normal in IFN-
R
/
mice, demonstrating
that IFN-
is not necessary for the promotion of T-cell
differentiation and T. cruzi-specific antibody responses.
 |
INTRODUCTION |
Trypanosoma cruzi is an
obligate intracellular protozoan parasite of mammals and the etiologic
agent of Chagas' disease. T. cruzi invades a variety of
host cell types and replicates within the cytoplasm. In humans and in
mice, infection with T. cruzi is followed by a severe
immunosuppression mediated by T cells (27) and macrophages
(9). Infected mice have a decreased ability to produce
interleukin-2 (IL-2) (30) and to display IL-2 receptors
(36) during the acute phase of infection. The acute phase is
characterized by a large increase in parasite replication which can be
monitored in the blood of the infected mice. However, immunocompetent
mice are able to control the parasite load by an inflammatory innate
and specific immune response but generally fail to completely eliminate
the parasite. This may eventually lead to chronic chagasic pathology,
in which autoimmune mechanisms also play a role (7).
Multiple components of both the innate and the adaptive immune system
are simultaneously required for protection during the acute phase of
infection, with gamma interferon (IFN-
) being an important mediator
of resistance to T. cruzi (29, 45). IFN-
is
believed to be produced by natural killer (NK) cells at the onset of
infection (8) and later also by CD4+
(38) and CD8+ (43) T cells.
Consequently, administration of recombinant IFN-
increases
resistance (33), whereas neutralization of endogenously produced IFN-
increases susceptibility during the acute phase of
infection (45). Moreover, IFN-
-activated macrophages are a major source of protective inflammatory cytokines and induce trypanocidal activities (19). The latter can be blocked by
L-arginine analogs that inhibit the induced nitric oxide
synthase (iNOS) pathway (47). In addition, nitric oxide (NO)
is released during the acute phase of T. cruzi infection in
mice, and treatment of such mice with inhibitors of NO synthase
exacerbates the infection (31, 47). While NO might be by
itself cytotoxic, it also reacts with superoxide
(O2
) to yield peroxynitrite
(ONOO
), a stronger cytotoxic molecule than its precursor
(4, 32), which causes lipid and thiol oxidation and
nitrosylation and nitrosylation of amino acids on target proteins and
is highly toxic for T. cruzi (13). In this report
we show the immunological consequence of T. cruzi infection
in the absence of IFN-
and iNOS by comparative in vivo studies using
IFN-
receptor (IFN-
R)- and iNOS-deficient (IFN-
R
/
and iNOS
/
, respectively)
mice. Evidence is presented that both types of mutant mice are
defective in NO production and trypanocidal activities, explaining
their similar and extreme susceptibilities. These data demonstrate the
crucial importance of IFN-
-dependent, iNOS-mediated NO effector
functions to resist acute T. cruzi infection. Despite an
impaired tumor necrosis factor alpha (TNF-
) and IL-1
response, other proinflammatory cytokine responses (e.g., IL-12, IFN-
, IL-6)
were rather normal. Moreover, antibody production by B cells and
isotype switching to immunoglobulin G2a (IgG2a) as well as T-cell
differentiation were also independent of IFN-
signalling.
 |
MATERIALS AND METHODS |
Mice and parasites.
Young adult (7- to 8-week-old)
IFN-
R
/
mice (21), 129sv wild-type mice
(IFN-
R+/+), iNOS
/
mice, and 129sv × C57BL/6 wild-type mice (iNOS+/+) (28),
maintained under specific-pathogen-free conditions, were used for the
experiments. iNOS-deficient mice were generously provided by J. D. MacMicking, C. Nathan (Cornell University Medical College, New York,
N.Y.), and J. S. Mudgett (Merck Research Laboratories, Rahway,
N.J.).
A cloned population of the reticulotropic Trypanosoma cruzi
strain Tulahuen (a kind gift from Simon Croft, London School of Hygiene
and Tropical Medicine, London, Great Britain) was routinely maintained
in mice. For experiments, groups of mice were intraperitoneally infected with trypomastigotes and the resulting parasitemia was monitored by hemacytometer counting of blood samples.
For preparation of inactivated T. cruzi (iTC), tissue
culture trypomastigotes, and trypanocidal assays, monolayers of LLC-MK2 cells (American Type Culture Collection [ATCC] CCL7.1) were infected and cultured in complete ISCOVES medium (Gibco, Paisley, Great Britain)
containing 10% heat-inactivated fetal calf serum (Gibco), 0.05 mM
2-mercaptoethanol (Roth, Karlsruhe, Germany), and penicillin and
streptomycin (100 U/ml and 100 µg/ml, respectively) (Biochrom, Berlin, Germany). Inactivation of culture trypomastigotes was performed
by 10 freeze-thaw cycles, as described previously (10).
Histopathological analyses.
Infected mice were killed by
cervical dislocation after 17 days of infection. Tissue specimens were
collected and fixed in paraformaldehyde (4% in phosphate-buffered
saline) for further processing. Paraffin-embedded tissue sections were
stained with hematoxylin-eosin and subjected to microscope analysis.
Trypanocidal assay.
T. cruzi trypomastigotes were
harvested from infected LLC-MK2 cells and were incubated overnight
before use in the trypanocidal assay (19). Amastigote
contamination was <15% for all assays.
Bone marrow cells from IFN-

R
/
,
iNOS
/
, and wild-type mice were flushed from mouse
femora and cultivated at a concentration of
5 × 10
5
cells per ml in hydrophobic Teflon film bags (Hereaus, Hanau,
Germany)
as previously described (
15). The culture medium contained
70% high-glucose-formulation Dulbecco's modified Eagle's Medium
(Gibco), supplemented with 2 mM
L-glutamine, 0.01 mM sodium
pyruvate,
5% heat-inactivated horse serum, 10% heat-inactivated fetal
calf
serum (Gibco), 0.05 mM 2-mercaptoethanol (Roth), penicillin and
streptomycin (100 U/ml and 100 µg/ml, respectively) (Biochrom),
and
30% L929 conditioned medium, as a source of macrophage
colony-stimulating
factor activity. L-cell conditioned medium was
prepared as previously
described (
15). After 10 days of
infection, a pure bone marrow
macrophage (BMM

) population developed
and cells were used for
the assays as previously described.
For infection, macrophages were washed, counted, and adjusted to a
concentration of 2.5 × 10
6 cells/ml; 0.2 ml of BMM

was added to each well of a Lab Tek
eight-chamber slide (Nunc,
Naperville, Ill.) and incubated for
2 h. After being washed three
times with Hanks balanced salt solution
(Gibco), BMM

were infected
with 50 µl of 2 × 10
7 parasites/ml, with a final
ratio of two parasites to one BMM

,
and incubated for 2 h.
Extracellular parasites were removed by
rinsing gently with Hanks
balanced salt solution. Intracellular
parasite elimination was
determined after a 2-day incubation with
complete media, supplemented
with recombinant murine IFN-

(100
or 10 U/ml), TNF-

(50 U/ml;
Pharmingen, San Diego, Calif.) (the
endotoxin level is <0.1 ng per
mg),
NG-monomethyl-
L-arginine
(
L-NMMA; 500 µM) (Calbiochem, San Diego,
Calif.), and
anti-IFN-

(500 ng/ml) (R4-6A2; ATCC) or lipopolysaccharide
(LPS) (10 µg/ml; Sigma, St. Louis, Mo.). Two hundred fifty cells
per duplicate
well were counted by light microscopy on Diff Quick
(Baxter Scientific,
Mundelein, Ill.)-stained slides. The percentage
of cells infected with
T. cruzi was recorded, and the percentage
of parasite
elimination was determined by the following calculation:
1

[%
infected cells
(stimulated)/% infected
cells
(medium)] ×
100%.
CD4+ and CD8+ T-cell enrichment.
Enrichment of the lymph node cell suspension for CD4+ cells
was performed by positive selection with magnetic mouse CD4 Dynabeads and mouse CD4 DETACHaBEAD (Dynal; Robbins Scientific, Mountain View,
Calif.). CD8+ cells were enriched by further incubation of
the CD4+-depleted cell suspension with anti-B220-specific
Dynabeads. Positive selected CD4+ cells from lymph nodes
contained <5% CD8+, and negative enriched
CD8+ cells contained <5% CD4+ cells, as
determined by flow cytometry analysis.
Determination of cytokines, T. cruzi-specific
antibodies, and nitrite.
Isolated cells were cultured in 48- or
96-well flat-bottom plates (Nunc) at 2 × 106/ml. The
cultures were stimulated either with iTC (4 × 106/ml), LPS (5 µg/ml; Sigma), or plate-bound anti-CD3
(30 µg/ml) (145-2C-11; ATCC). Cell supernatants from the cultures
were harvested after 24 or 48 h of culture.
Cytokine levels in the plasma and culture supernatants were detected by
sandwich enzyme-linked immunosorbent assays as described
previously
(
11). Plasma and culture supernatants and appropriate
standards (Pharmingen) were used in threefold serial dilutions.
The
coating and biotinylated detection antibodies for IFN-

, TNF-

,
IL-4, IL-6, and IL-12 were purchased from Pharmingen. The unlabelled
rabbit and hamster anti-IL-1

antibodies were from Genzyme
(Cambridge,
Mass.), and the biotinylated anti-rabbit antibody was from
Southern
Biotechnology (Birmingham, Ala.). Alkaline phosphatase coupled
to streptavidin (Southern Biotechnology) was used to stain the
detection antibodies. The cytokines and their detection levels
were as
follows: IFN-

, 0.2 ng/ml; TNF-

, 0.05 ng/ml; IL-1

, 0.1
ng/ml;
IL-4, 1 ng/ml; IL-6, 0.3 ng/ml; and IL-12, 0.3 ng/ml.
For antigen-specific antibody detection, plates were coated with
10
4 inactivated trypomastigotes/well and incubated with the
plasma
of individual animals bled at day 0 and day 17 after infection,
followed by incubation with alkaline phosphatase-conjugated
isotype-specific
antibodies for Ig, IgM, IgG1, IgG2a, IgG2b, and IgG3
(Southern
Biotechnology). All assays were developed with
p-nitrophenyl phosphate
(Sigma).
The nitrite content in serial diluted triplicates was measured by
adding 50 µl of freshly prepared Griess reagent to 50 µl
of the
samples in 96-well plates and reading the optical density
at 550 nm
after 10 min and subsequently comparing it with the
optical density
curves of serial dilutions of sodium nitrite in
normal plasma or
complete culture medium. For plasma nitrite quantification,
the Griess
reaction was used as described previously (
35).
 |
RESULTS |
IFN-
R
/
and iNOS
/
mice are unable
to survive acute T. cruzi infection with similar
parasitemias and mortality kinetics.
IFN-
R
/
mice on a 129sv background were infected regularly with sublethal doses
of 100 trypomastigotes of T. cruzi, and the course of
infection was compared with that of similarly infected 129sv wild-type
mice (50% lethal dose = 250 trypomastigotes). During the acute
phase of infection, mutant mice exhibited an earlier onset and an
increased level (15-fold) of parasitemia compared to infected controls
(Fig. 1a). Moreover, all mutant mice died
between days 14 and 21 (Fig. 1b) whereas most wild-type mice survived
acute infection. By reducing the infection dose to 15 or 50 parasites,
mortality was delayed. Nevertheless, all mutant mice died within 28 and
33 days postinfection. These results demonstrate the extreme
susceptibility of IFN-
R
/
mice and their inability to
survive T. cruzi infection. Similar experiments were
performed with iNOS
/
mice and their wild-type controls
(129sv × C57BL/6). When sublethal doses of 15 trypomastigotes
were used, all mutant mice showed earlier and fivefold-exacerbated
parasitemia (Fig. 1c) and died between day 21 and 26 (Fig. 1d), whereas
most wild-type mice survived acute infection. These results demonstrate
the extreme susceptibility of iNOS
/
mice and their
inability to survive T. cruzi infection. In conclusion, both
IFN-
and iNOS seem to have key functions which are crucial in
surviving the acute phase of T. cruzi infection.

View larger version (33K):
[in this window]
[in a new window]
|
FIG. 1.
Parasitemia and survival of mutant mice infected with
T. cruzi. IFN- R / (open symbols) and
wild-type (closed symbols) mice were each infected with 100 blood
trypomastigotes, and the subsequent parasitemia (trypomastigotes
per microliter) (a) was observed as described in Materials and Methods.
Mice were each infected with 100 ( , ), 50 ( ), or 15 ( )
blood trypomastigotes, and survival (b) was monitored.
iNOS / (open symbols) and wild-type (closed symbols)
mice were each infected with 15 blood trypomastigotes, and parasitemia
(trypomastigotes per microliter) (c) and survival (d) were monitored.
Results are expressed as the means ± standard deviations (error
bars) of five mice/group.
|
|
Extensive necrotic lesions and parasite dissemination in infected
IFN-
R
/
and iNOS
/
mice.
On day
17 postinfection, the liver (Fig. 2a and
b), heart, and spleen (not shown) of infected wild-type mouse strains
showed comparably low numbers of parasite-infected cells, with
inflammatory mononuclear cell infiltration in the liver and spleen but
without histopathological lesions in these organs. In contrast, the
infected organs of IFN-
R
/
and iNOS
/
mice revealed an increased parasite burden accompanied by large necrotic lesions at the sites of infection in the liver (Fig. 2c and d)
and spleen (not shown). Furthermore, amastigote nests were found in the
cytoplasm of infected cells and disseminated parasites were found in
the necrotic areas (Fig. 2e and f). Infected organs of
IFN-
R
/
mice showed more and larger parasite nests
than those of iNOS
/
mice, in accordance with the
observed higher parasitemia of the former (Fig. 1). In summary, these
results strongly suggest that both mutant mouse strains succumb to the
pathophysiology of the infection, which is typical for a severe acute
phase of experimental Chagas' disease. Moreover, the correlation of
comparable early parasitemias and mortality kinetics when taken
together with the similar pathophysiologies observed in
IFN-
R
/
and iNOS
/
mice may indicate
related immunological mechanisms. These possibilities were further
investigated.

View larger version (175K):
[in this window]
[in a new window]
|
FIG. 2.
Histopathology of heart and liver tissues from T. cruzi-infected IFN- R / and iNOS /
mice. IFN- R / and control mice were each infected
with 100 trypomastigotes, iNOS / and control mice were
each infected with 50 trypomastigotes, and hematoxylin-eosin-stained
sections were prepared at 17 days postinfection. Liver tissue from
IFN- R+/+ (a) and iNOS+/+ (b) control mice
showed comparable multiple small foci of mononuclear cell infiltration
with minimal tissue damage. In contrast, liver tissue from
IFN- R / (c and e) and iNOS / (d and f)
mice showed severe destruction (>60%) of the liver parenchyma with
confluent necrosis. Mononuclear cell infiltration was comparable in
both groups of deficient mice, but parasite numbers and amastigote nest
sizes in the liver were greater in IFN- R / mice (e)
than in iNOS / mice (f). IFN- R / (g)
and iNOS / (h) heart sections showed many amastigote
nests but poor inflammatory cell infiltrates. Shown are representative
sections from five individual analyzed mice/group. Bar = 0.03 mm.
|
|
Impaired TNF-
and IL-1
responses in IFN-
R
/
mice but normal inflammatory cytokine responses in
iNOS
/
mice after infection with T. cruzi.
The activation of macrophages by IFN-
is one major function of a
protective inflammatory cytokine response. To determine if these
responses were different in the various mutant mouse strains, we
measured the in vivo production of IFN-
, TNF-
, and IL-1
in the
blood of infected mice 7 and 10 days postinfection. IFN-
R
/
mice showed elevated levels of IFN-
but
reduced TNF-
and IL-
levels compared to those of wild-type
controls (Fig. 3a and c). In contrast,
these inflammatory cytokine responses were normal in
iNOS
/
mice (Fig. 3b and d). To determine the
contribution of T cells and macrophages to this inflammatory response,
spleen cells from infected IFN-
R
/
,
iNOS
/
, and wild-type mice were isolated at day 10 postinfection and restimulated with iTC, LPS, or anti-CD3 (Fig.
4). Only cells from infected mice were
able to induce a cytokine response to iTC (data not shown). After
restimulation with iTC and LPS, IFN-
R
/
mouse-derived
spleen cells showed a striking reduction of IL-1
production and an
impaired TNF-
secretion after restimulation with LPS (Fig. 4). After
iTC restimulation, TNF-
levels were also reduced but varied in
different experiments. In contrast, production of IL-6 and IL-12 was
not affected in response to iTC and LPS (Fig. 4). Similar results were
found with iTC-restimulated peritoneal exudate cells (data not shown).
The overall anti-CD3 induced cytokine responses were rather low (Fig.
4), with the exception of IFN-
, indicating that T cells were not
major contributors to the measured IL-1
, TNF-
, and IL-6
inflammatory cytokine responses at this point of the infection course.
LPS and iTC restimulation induced similar cytokine levels, suggesting
that macrophages are the major contributors to the IL-12, IL-1
,
TNF-
, and IL-6 responses. Therefore, the impaired TNF-
and
IL-1
production is probably caused by defective
IFN-
R
/
macrophages. However, neither T. cruzi-induced production of IFN-
itself nor that of IL-12 or
IL-6 was impaired in these mice, suggesting that cell activation by
IFN-
is not mandatory for sufficient production of these
cytokines in this particular infection model.

View larger version (34K):
[in this window]
[in a new window]
|
FIG. 3.
Levels of IFN- , TNF- , and IL-1 in plasma.
Groups of five IFN- R / (a and c) or
iNOS / (b and d) mice (open bars) and their wild-type
controls (hatched bars) were each infected with 1,000 or 500 blood
trypomastigotes, and the cytokine content of the plasma was determined
7 (a and b) and 10 (c and d) days postinfection as described in
Materials and Methods. Asterisks indicate statistically significant
differences (P < 0.05) from values of wild-type
controls as calculated by Student's t test. Error bars,
standard deviations.
|
|

View larger version (34K):
[in this window]
[in a new window]
|
FIG. 4.
Cytokine synthesis from restimulated
IFN- R / spleen cells. Mice were each infected with
1,000 blood trypomastigotes of the Tulahuen strain of T. cruzi. At day 10, spleen cells of wild-type (hatched bars) and
IFN- R / (open bars) mice were isolated and cultured
for 48 h in the presence of either anti-CD3, iTC, LPS, or medium
alone, and the cytokine levels of the cell culture supernatants were
determined as described in Materials and Methods. For the experiment
whose results are shown, the pooled cells of five mice per group were
used. Results are expressed as the means + standard deviations
(error bars) of triplicate wells. Asterisks indicate statistically
significant differences (P < 0.05) from values of
wild-type controls as calculated by Student's t test and
are shown only for cases in which statistically significant differences
were found in two independent experiments.
|
|
Spleen cells from iNOS
/
mice showed comparable IFN-

,
IL-1

, TNF-

, and IL-6 levels after restimulation with iTC, LPS,
and
anti-CD3 (data not shown). In conclusion, the absence of iNOS
appears not to affect a protective inflammatory cytokine response
to
T. cruzi.
Normal T. cruzi-specific antibody response and T-cell
polarization in IFN-
R
/
mice.
To analyze
specific immune responses in IFN-
R
/
mice, T. cruzi-specific antibody titers were determined 14 days
postinfection with 100 trypomastigotes (Fig.
5). T-cell polarization into Th1/Th2 and
Tc1/Tc2 effector cells was determined following restimulation with
immobilized anti-CD3 of enriched CD4+ and CD8+
lymph node-derived T cells (Fig. 6).
Slightly increased T. cruzi-specific antibody titers of all
measured isotypes, including antigen-specific IgG2a, were observed in
IFN-
R
/
mice. Moreover, normal IFN-
and IL-4
levels were found in the supernatants of the T-cell subsets of mutant
mice, suggesting an unaltered Th1/Th2 and Tc1/Tc2 polarization. In
summary, these data suggest normal T-cell polarization and normal
B-cell antibody responses in T. cruzi-infected
IFN-
R
/
mice.

View larger version (22K):
[in this window]
[in a new window]
|
FIG. 5.
Immunoglobulin isotype distribution in plasma of
IFN- R / mice each infected with 100 blood
trypomastigotes of the Tulahuen strain of T. cruzi. Blood
was collected from wild-type (closed symbols) and
IFN- R / (open symbols) mice at day 17 postinfection.
Ig isotypes of trypomastigote-specific antibodies in plasma were
determined by an antigen-specific enzyme-linked immunosorbent assay as
described in Materials and Methods. Antibody titers of individual mice
are shown. Horizontal bars indicate mean values of five mice/group.
Comparable results were obtained in another independent experiment.
|
|

View larger version (38K):
[in this window]
[in a new window]
|
FIG. 6.
IFN- and IL-4 synthesis of CD4+ and
CD8+ cells from IFN- R / mice each
infected with 1,000 blood trypomastigotes. At day 14 postinfection,
lymph node cells and sorted CD4+ and CD8+ cells
of wild-type (hatched bars) and IFN- R / (open bars)
mice were cultured for 48 h in the presence of immobilized
anti-CD3 and the cytokine secretion in the supernatants was determined
as described in Materials and Methods. In the experiment shown, pooled
cells of five mice per group were used. Results are expressed as the
means + standard deviations (error bars) of triplicate wells.
Comparable results were obtained in another independent experiment.
|
|
Defective trypanocidal and NO activity of IFN-
R
/
and iNOS
/
macrophages.
After infection with
T. cruzi, activated macrophages and other cells produce NO,
an effector molecule able to kill T. cruzi (19).
In T. cruzi-infected wild-type mice, substantial production of NO was measured in the blood (>40 mM) and supernatants of iTC- or
LPS-restimulated peritoneal exudate and spleen cells (>30 mM) (Table
1), demonstrating an effective NO
response in these mice. In contrast, iNOS
/
mice showed
only low-level NO production in vivo (<1.5 mM) and after antigen or
LPS restimulation in vitro (<1.5 mM) (Table 1). Moreover, infected
IFN-
R
/
mice were also strikingly impaired in their
ability to produce NO in vivo (<1.5 mM) and in vitro (1.7 to 6.3 mM)
(Table 1), suggesting an IFN-
dependency for effective NO
production. This suggestion was confirmed by using mutant and wild-type
BMM
. T. cruzi-infected mutant macrophages were unable to
induce a NO response and a reduction of intracellular amastigotes (Fig.
7). For NO production and mediation of
their following function, T. cruzi-infected wild-type
macrophages required incubation with IFN-
. Both NO production and
trypanocidal activities could be inhibited by coincubation with the
iNOS inhibitor L-NMMA or by a neutralizing IFN-
antibody (Fig. 7). This demonstrates and confirms an IFN-
dependency of iNOS-mediated NO production as a major defense effector molecule for
T. cruzi. In conclusion, these in vivo and in vitro results strongly suggest that the NO defect in infected
IFN-
R
/
and iNOS
/
mice was
responsible for their inability to kill intracellular T. cruzi, which in turn led to severe acute experimental Chagas' disease and eventually death.

View larger version (19K):
[in this window]
[in a new window]
|
FIG. 7.
Trypanocidal activity and NO production of
IFN- R / (a) and iNOS / (b)
mouse-derived BMM after in vitro infection with T. cruzi.
BMM were isolated from femora of naive wild-type (hatched bars) or
naive mutant (open bars) mice, infected with T. cruzi
trypomastigotes, and incubated with medium alone, IFN- (100 U/ml),
IFN- (100 U/ml) plus L-NMMA (500 µM), or IFN- (100 U/ml) plus anti-IFN- (500 ng/ml) as described in Materials and
Methods. Two days later, the NO content of the supernatants and the
percentage of T. cruzi-infected cells (250 scored
cells/well) were determined in relation to those for infected BMM
incubated with medium alone. Comparable results were obtained in
another independent experiment. Error bars, standard deviations.
|
|
 |
DISCUSSION |
Both IFN-
R
/
and iNOS
/
mice
showed related susceptibilities to T. cruzi and succumbed
during the acute phase of infection, with similar mortality kinetics
and severe acute Chagas' disease, even after infection with very low
doses of trypomastigotes. We were able to demonstrate a common defect,
responsible for the severe outcome of the disease. Both mutant strains
were unable to produce NO in response to infection with T. cruzi in vivo and in vitro. Moreover, macrophages from both mutant
mouse strains were defective in trypanocidal activities and parasites
developed rapidly in these cells. These results strongly suggest the
crucial importance of iNOS-mediated NO production as the major defense
mechanism for surviving in vivo T. cruzi infection. A
similarly crucial role of NO effector functions has been observed in
experimental infections with Leishmania major (42,
48) and Mycobacterium bovis (3, 49).
However, the importance of NO-mediated defense functions against
intracellular pathogens cannot be generalized. For example, in
toxoplasmosis or listeriosis the role of this effector mechanism is
rather limited (14, 23, 28, 40) and other mechanisms seem to
play a protective role.
On the other hand, IFN-
is a crucial cytokine in all the
above-mentioned diseases, as IFN-
/
or
IFN-
R
/
mice are unable to survive these infections
(6, 12, 24, 39, 46). After activation of the IFN-
R on
macrophages, various tyrosine kinases are induced and proteins that are
signal transducers and activators of transcription are phosphorylated,
both of which regulate the induction and activation of transcription
factors of the interferon regulatory factor family. Among these,
interferon regulatory factor 1 directly mediates the expression of iNOS
and subsequently the production of NO (22). We have shown
that this IFN-
-dependent iNOS expression (18, 19, 47) and
the consequent NO production seem to be mandatory for surviving
T. cruzi infection. However, recent studies have shown
evidence that T. cruzi-infected IFN-
R
/
mice are able to express low but detectable levels of iNOS mRNA, suggesting a dual pathway of iNOS induction and subsequent NO production (37). We also observed some residual NO in
T. cruzi-infected IFN-
R
/
peritoneal
exudate cells (Table 1). Interestingly, IFN-
-independent iNOS
protein has been located in a different subcellular compartment than
IFN-
-dependent iNOS and could be localized on the membranes of
amastigotes within parasite nests (37). Rottenberg et al. hypothesized that IFN-
-independent iNOS may be involved in the enhancement of parasite proliferation (37). In
Listeria monocytogenes-infected IFN-
R
/
mice, a similar IFN-
-independent pathway of iNOS expression was
observed (12). In this case, neutrophils were major
contributors to the overall iNOS transcript levels (unpublished data).
Nevertheless, in experimental listeriosis NO effector functions have a
limited protective capacity. Different IFN-
-dependent effector
mechanisms, such as the subsequent fusion of the phagosome with the
lysosomal compartment, may be involved in efficient pathogen
elimination (12).
In contrast to iNOS-deficient mice, which showed a normal
proinflammatory cytokine response to T. cruzi infection,
infected IFN-
R
/
mice showed impaired TNF-
and
IL-1
production in vivo and after in vitro restimulation with LPS.
These data suggest that IFN-
R
/
macrophages are
defective in mediating these cytokine responses, demonstrating that
TNF-
and IL-1
production is dependent on IFN-
activation. This
impaired cytokine production may contribute to the observed
susceptibility of IFN-
R
/
mice, since a protective
role of TNF-
and IL-1
in experimental Chagas' disease has been
demonstrated (1, 26, 34). In contrast, in vitro IL-12 and
IL-6 responses after antigen and LPS restimulation were comparable with
those of the controls, suggesting that T. cruzi-induced
expression of these cytokines by macrophages is independent of IFN-
R
signalling. An IFN-
-independent IL-12 response is in agreement with
recent data which show that T. cruzi is able to induce IL-12
directly in macrophages without priming by IFN-
(2, 16),
as has been found in other infection models, e.g., L. monocytogenes (20), Staphylococcus aureus
(5), and Toxoplasma gondii (17). IL-12
induces IFN-
production by NK cells, which in turn leads to
IFN-
-dependent macrophage stimulation and subsequent activation of
an effector function, which promotes an efficient early innate immune
response. Normal IL-12 production after antigen restimulation of
IFN-
R
/
spleen or peritoneal exudate cells indicates
that further stimulation by IFN-
in a positive feedback loop is not
mandatory for efficient production of both cytokines. This was recently
demonstrated also in Listeria-infected
IFN-
R
/
mice (12). IL-12 is important in
promoting Th1 development, which bridges innate and adoptive immunity
(6) and leads to a Th1-type response which is usually
protective in intracellular infections. As infected
IFN-
R
/
mice showed normal T-cell polarization, we
suggest that sufficient IL-12 was present in these mice. The role of
IFN-
in directing T-cell differentiation is controversial, as in
vitro studies and L. major infection studies using IFN-
-
and IFN-
R-deficient mice showed contradictary results
(6). However, the normal Th1/Th2 and Tc1/Tc2 responses
during T. cruzi infection in IFN-
R
/
mice
strongly suggest that IFN-
is not crucial in the T-cell polarization. As IFN-
R
/
-IL-4
/
double-deficient mice had a prolonged survival time (unpublished data),
the absence of a Th2 response due to IL-4 deficiency
(IL-4
/
) (25) may partially compensate for
the impaired macrophage response. Nevertheless, normal mice seem to
develop an optimal Th1 response, as no significant change in
parasitemia and survival rate during the acute phase of infection was
found in infected IL-4
/
and wild-type mice (unpublished
results).
NO is known to be involved in immune response regulation in that it
inhibits the expansion of cloned Th1 but not Th2 cells (44).
Consistently, restimulated spleen cells of L. major-infected iNOS
/
mice produce more IFN-
but less IL-4 than do
wild-type mice (48). Moreover, an enhanced T-cell
proliferation was found after inactivation of NO production of spleen
cells isolated from T. cruzi-infected wild-type mice
(1). Despite these observed down-regulatory properties of NO
on T cells, the absence of inflammatory NO in T. cruzi-infected IFN-
R
/
mice seemed not to have
any effects on T-cell differentiation. We have not directly addressed
T-cell differentiation in iNOS
/
mice. However,
restimulation of splenic T cells from T. cruzi-infected iNOS
/
mice showed no increased IFN-
levels compared
to controls, indicating that in the absence of iNOS-mediated NO
production Th1 responses were not increased.
The normal T-cell polarization in IFN-
R
/
mice may
also explain the normal humoral responses found with respect to
T. cruzi-specific antibody production observed.
Antigen-specific IgG2a response was also normal in
IFN-
R
/
mice, even though IFN-
is known to
regulate IgG2a isotype switches (41), shown by reduced
2,4-dinitrophenol-ovalbumin-specific IgG2a responses in
IFN-R
/
mice after immunization (21).
However, our results suggest that T. cruzi-specific IgG2a
responses are independent of IFN-
signalling and that other factors
may be involved in this isotype regulation.
In summary, these data demonstrate the limited effect of IFN-
R
signalling on lymphocyte-specific immune responses in experimental Chagas' disease. IFN-
-independent but parasite-induced IL-12 seems
to initiate and mediate the normal T-cell response observed in
susceptible IFN-
R
/
mice. This response is protective
in immunocompetent mice. Hence, IFN-
-dependent and iNOS-mediated NO
production is crucial for macrophage trypanocidal activity and survival
by mice of the acute phase of T. cruzi infection.
 |
ACKNOWLEDGMENTS |
We thank Simon Croft for providing the Tulahuen clone, C. Galanos
for supplying LPS, and J. Wood for reviewing the manuscript. We are
also grateful to M. Aguet, J. MacMicking, C. Nathan, and J. Mudgett for
breeding pairs of IFN-
R
/
and iNOS
/
mice.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Immunology, University of Cape Town, H53, H Floor, Old Main Building, Groote Schoor Hospital, Observatory, Cape Town 7925, South Africa. Phone: 27-21/406-6147. Fax: 27-21/448-6116. E-mail:
fbrombac{at}samiot.uct.act.za.
Editor: S. H. E. Kaufmann
 |
REFERENCES |
| 1.
|
Abrahamsohn, I. A., and R. L. Coffman.
1996.
Trypanosoma cruzi IL-10, TNF, IFN-gamma, and IL-12 regulate innate and acquired-immunity to infection.
Exp. Parasitol.
84:231-244[Medline].
|
| 2.
|
Aliberti, J. C.,
M. A. Cardoso,
G. A. Martins,
R. T. Gazzinelli,
L. Q. Vieira, and J. S. Silva.
1996.
Interleukin-12 mediates resistance to Trypanosoma cruzi in mice and is produced by murine macrophages in response to live trypomastigotes.
Infect. Immun.
64:1961-1967[Abstract/Free Full Text].
|
| 3.
|
Barrera, L. F.,
I. Kramnik,
E. Skamene, and D. Radzioch.
1994.
Nitrite production by macrophages derived from BCG-resistant and -susceptible congenic mouse strains in response to IFN-gamma and infection with BCG.
Immunology
82:457-464[Medline].
|
| 4.
|
Beckman, J. S.
1991.
The double-edged role of nitric oxide in brain function and superoxide-mediated injury.
J. Dev. Physiol.
15:53-59[Medline].
|
| 5.
|
Biron, C. A., and R. T. Gazzinelli.
1995.
Effects of IL-12 on immune responses to microbial infections: a key mediator in regulating disease outcome.
Curr. Opin. Immunol.
7:485-496[Medline].
|
| 6.
|
Brombacher, F., and M. Kopf.
1996.
Innate versus acquired immunity in listeriosis.
Res. Immunol.
147:505-511[Medline].
|
| 7.
|
Cardillo, F.,
R. P. Falcao,
M. A. Rossi, and J. Mengel.
1993.
An age-related gamma delta T cell suppressor activity correlates with the outcome of autoimmunity in experimental Trypanosoma cruzi infection.
Eur. J. Immunol.
23:2597-2605[Medline].
|
| 8.
|
Cardillo, F.,
J. C. Voltarelli,
S. G. Reed, and J. S. Silva.
1996.
Regulation of Trypanosoma cruzi infection in mice by gamma interferon and interleukin 10: role of NK cells.
Infect. Immun.
64:128-134[Abstract/Free Full Text].
|
| 9.
|
Cunningham, D. S., and R. E. Kuhn.
1980.
Trypanosoma cruzi-induced suppression of the primary immune response in murine cell cultures to T-cell-dependent and -independent antigens.
J. Parasitol.
66:16-27[Medline].
|
| 10.
|
Curotto de Lafaille, M. A.,
L. C. Barbosa de Oliveira,
G. C. Lima, and I. A. Abrahamsohn.
1990.
Trypanosoma cruzi: maintenance of parasite-specific T cell responses in lymph nodes during the acute phase of the infection.
Exp. Parasitol.
70:164-174[Medline].
|
| 11.
|
Dai, W. D.,
G. Köhler, and F. Brombacher.
1997.
Both innate and acquired immunity to Listeria monocytogenes infection are increased in IL-10 deficient mice.
J. Immunol.
158:2259-2267[Abstract].
|
| 12.
|
Dai, W. J.,
W. Bartens,
G. Kohler,
M. Hufnagel,
M. Kopf, and F. Brombacher.
1997.
Impaired macrophage listericidal and cytokine activities are responsible for the rapid death of Listeria monocytogenes-infected IFN-gamma receptor-deficient mice.
J. Immunol.
158:5297-5304[Abstract].
|
| 13.
|
Denicola, A.,
H. Rubbo,
D. Rodriguez, and R. Radi.
1993.
Peroxynitrite-mediated cytotoxicity to Trypanosoma cruzi.
Arch. Biochem. Biophys.
304:279-286[Medline].
|
| 14.
|
Fehr, T.,
G. Schoedon,
B. Odermatt,
T. Holtschke,
M. Schneemann,
M. F. Bachmann,
T. W. Mak,
I. Horak, and R. M. Zinkernagel.
1997.
Crucial role of interferon consensus sequence binding protein, but neither of interferon regulatory factor 1 nor of nitric oxide synthesis for protection against murine listeriosis.
J. Exp. Med.
185:921-931[Abstract/Free Full Text].
|
| 15.
|
Flesch, I.,
B. Ecker, and E. Ferber.
1984.
Acyltransferase-catalyzed cleavage of arachidonic acid from phospholipids and transfer to lysophosphatides in macrophages derived from bone marrow. Comparison of different donor- and acceptor substrate combinations.
Eur. J. Biochem.
139:431-437[Medline].
|
| 16.
|
Frosch, S.,
S. Kraus, and B. Fleischer.
1996.
Trypanosoma cruzi is a potent inducer of interleukin-12 production in macrophages.
Med. Microbiol. Immunol.
185:189-193[Medline].
|
| 17.
|
Gazzinelli, R. T.,
S. Hieny,
T. A. Wynn,
S. Wolf, and A. Sher.
1993.
Interleukin 12 is required for the T-lymphocyte-independent induction of interferon gamma by an intracellular parasite and induces resistance in T-cell-deficient hosts.
Proc. Natl. Acad. Sci. USA
90:6115-6119[Abstract/Free Full Text].
|
| 18.
|
Gazzinelli, R. T.,
I. P. Oswald,
S. L. James, and A. Sher.
1992.
IL-10 inhibits parasite killing and nitrogen oxide production by IFN-gamma-activated macrophages.
J. Immunol.
148:1792-1796[Abstract].
|
| 19.
|
Golden, J. M., and R. L. Tarleton.
1991.
Trypanosoma cruzi: cytokine effects on macrophage trypanocidal activity.
Exp. Parasitol.
72:391-402[Medline].
|
| 20.
|
Hsieh, C. S.,
S. E. Macatonia,
C. S. Tripp,
S. F. Wolf,
A. O'Garra, and K. M. Murphy.
1993.
Development of T(H)1 CD4(+) T cells through IL-12 produced by Listeria-induced macrophages.
Science
260:547-549[Abstract/Free Full Text].
|
| 21.
|
Huang, S.,
W. Hendriks,
A. Althage,
S. Hemmi,
H. Bluethmann,
R. Kamijo,
J. Vilcek,
R. M. Zinkernagel, and M. Aguet.
1993.
Immune response in mice that lack the interferon-gamma receptor.
Science
259:1742-1745[Abstract/Free Full Text].
|
| 22.
|
Kamijo, R.,
H. Harada,
T. Matsuyama,
M. Bosland,
J. Gerecitano,
D. Shapiro,
J. Le,
S. I. Koh,
T. Kimura,
S. J. Green,
T. W. Mak,
T. Taniguchi, and J. Vilcek.
1994.
Requirement for transcription factor IRF-1 in NO synthase induction in macrophages.
Science
263:1612-1615[Abstract/Free Full Text].
|
| 23.
|
Khan, I. A.,
T. Matsuura,
S. Fonseka, and L. H. Kasper.
1996.
Production of nitric oxide (NO) is not essential for protection against acute Toxoplasma gondii infection in IRF-1 / mice.
J. Immunol.
156:636-643[Abstract].
|
| 24.
|
Kopf, M.,
F. Brombacher,
G. Kienzle,
K.-H. Widmann,
K. Lefranc,
C. Humborg,
B. Ledermann, and W. Solbach.
1996.
IL-4-deficient mice without elevating Th1 responses resist infection with Leishmania major.
J. Exp. Med.
184:1127-1136[Abstract/Free Full Text].
|
| 25.
|
Kopf, M.,
G. LeGros,
A. Coyle,
M. Kosco-Vilbois, and F. Brombacher.
1995.
Immune responses of IL-4, IL-5, IL-6 deficient mice.
Immunol. Rev.
148:45-69[Medline].
|
| 26.
|
Lima, E. C. S.,
I. Garcia,
M.-H. Vicentelli,
P. Vassalli, and P. Minoprio.
1997.
Evidence for a protective role of tumor necrosis factor in the acute phase of Trypanosoma cruzi infection in mice.
Infect. Immun.
65:457-465[Abstract/Free Full Text].
|
| 27.
|
Lopes, M. F., and G. A. Dos Reis.
1994.
Trypanosoma cruzi-induced immunosuppression: blockade of costimulatory T-cell responses in infected hosts due to defective T-cell receptor-CD3 functioning.
Infect. Immun.
62:1484-1488[Abstract/Free Full Text].
|
| 28.
|
MacMicking, J. D.,
C. Nathan,
G. Hom,
N. Chartrain,
D. S. Fletcher,
M. Trumbauer,
K. Stevens,
Q. W. Xie,
K. Sokol,
N. Hutchinson, et al.
1995.
Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase.
Cell
81:641-650[Medline].
|
| 29.
|
McCabe, R. E.,
S. G. Meagher, and B. T. Mullins.
1991.
Endogenous interferon-gamma, macrophage activation, and murine host defense against acute infection with Trypanosoma cruzi.
J. Infect. Dis.
163:912-915[Medline].
|
| 30.
|
Nabors, G. S., and R. L. Tarleton.
1991.
Differential control of IFN-gamma and IL-2 production during Trypanosoma cruzi infection.
J. Immunol.
146:3591-3598[Abstract].
|
| 31.
|
Petray, P.,
M. E. Rottenberg,
S. Grinstein, and A. Orn.
1994.
Release of nitric oxide during the experimental infection with Trypanosoma cruzi.
Parasite Immunol.
16:193-199[Medline].
|
| 32.
|
Radi, R.,
J. S. Beckman,
K. M. Bush, and B. A. Freeman.
1991.
Peroxynitrite-induced membrane lipid peroxidation: the cytotoxic potential of superoxide and nitric oxide.
Arch. Biochem. Biophys.
288:481-487[Medline].
|
| 33.
|
Reed, S. G.
1988.
In vivo administration of recombinant IFN-gamma induces macrophage activation and prevents acute disease, immune suppression, and death in experimental Trypanosoma cruzi infections.
J. Immunol.
140:4342-4347[Abstract].
|
| 34.
|
Reed, S. G.,
D. L. Pihl, and K. H. Grabstein.
1989.
Immune deficiency in chronic Trypanosoma cruzi infection. Recombinant IL-1 restores Th function for antibody production.
J. Immunol.
142:2067-2071[Abstract].
|
| 35.
|
Rockett, K. A.,
M. M. Awburn,
E. J. Rockett, and I. A. Clark.
1994.
Tumor necrosis factor and interleukin-1 synergy in the context of malaria pathology.
Am. J. Trop. Med. Hyg.
50:735-742.
|
| 36.
|
Rottenberg, M.,
C. Lindqvist,
A. Koman,
E. L. Segura, and A. Orn.
1989.
Modulation of both interleukin 2 receptor expression and interleukin 2 production during experimental murine Trypanosoma cruzi infection.
Scand. J. Immunol.
30:65-72[Medline].
|
| 37.
|
Rottenberg, M. E.,
E. Castanos-Velez,
R. de Mesquita,
O. G. Laguardia,
P. Biberfeld, and A. Orn.
1996.
Intracellular co-localization of Trypanosoma cruzi and inducible nitric oxide synthase (iNOS): evidence for dual pathway of iNOS induction.
Eur. J. Immunol.
26:3203-3213[Medline].
|
| 38.
|
Russo, M.,
N. Starobinas,
P. Minoprio,
A. Coutinho, and M. Hontebeyrie-Joskowicz.
1988.
Parasitic load increases and myocardial inflammation decreases in Trypanosoma cruzi-infected mice after inactivation of helper T cells.
Ann. Inst. Pasteur Immunol.
139:225-236[Medline].
|
| 39.
|
Scharton, K. T.,
T. A. Wynn,
E. Y. Denkers,
S. Bala,
E. Grunvald,
S. Hieny,
R. T. Gazzinelli, and A. Sher.
1996.
In the absence of endogenous IFN-gamma, mice develop unimpaired IL-12 responses to Toxoplasma gondii while failing to control acute infection.
J. Immunol.
157:4045-4054[Abstract].
|
| 40.
|
Scharton-Kersten, T. M.,
G. Yap,
J. Magram, and A. Sher.
1997.
Inducible nitric oxide is essential for host control of persistent but not acute infection with the intracellular pathogen Toxoplasma gondii.
J. Exp. Med.
185:1261-1273[Abstract/Free Full Text].
|
| 41.
|
Snapper, C. M., and W. E. Paul.
1987.
Interferon-gamma and B cell stimulatory factor-1 reciprocally regulate Ig isotype production.
Science
236:944-947[Abstract/Free Full Text].
|
| 42.
|
Stenger, S.,
N. Donhauser,
H. Thuring,
M. Rollinghoff, and C. Bogdan.
1996.
Reactivation of latent leishmaniasis by inhibition of inducible nitric oxide synthase.
J. Exp. Med.
183:1501-1514[Abstract/Free Full Text].
|
| 43.
|
Tarleton, R. L.
1990.
Depletion of CD8+ T cells increases susceptibility and reverses vaccine-induced immunity in mice infected with Trypanosoma cruzi.
J. Immunol.
144:717-724[Abstract].
|
| 44.
|
Taylor-Robinson, A. W.,
F. Y. Liew,
A. Severn,
D. Xu,
S. J. McSorley,
P. Garside,
J. Padron, and R. S. Phillips.
1994.
Regulation of the immune response by nitric oxide differentially produced by T helper type 1 and T helper type 2 cells.
Eur. J. Immunol.
24:980-984[Medline].
|
| 45.
|
Torrico, F.,
H. Heremans,
M. T. Rivera,
E. Van Marck,
A. Billiau, and Y. Carlier.
1991.
Endogenous IFN-gamma is required for resistance to acute Trypanosoma cruzi infection in mice.
J. Immunol.
146:3626-3632[Abstract].
|
| 46.
|
Van der Broek, M. F.,
U. Mueller,
S. Huang,
R. M. Zinkernagel, and M. Aguet.
1995.
Immune defence in mice lacking type I and/or type II interferon receptors.
Immunol. Rev.
148:5-18[Medline].
|
| 47.
|
Vespa, G. N.,
F. Q. Cunha, and J. S. Silva.
1994.
Nitric oxide is involved in control of Trypanosoma cruzi-induced parasitemia and directly kills the parasite in vitro.
Infect. Immun.
62:5177-5182[Abstract/Free Full Text].
|
| 48.
|
Wei, X. Q.,
I. G. Charles,
A. Smith,
J. Ure,
G. J. Feng,
F. P. Huang,
D. Xu,
W. Muller,
S. Moncada, and F. Y. Liew.
1995.
Altered immune responses in mice lacking inducible nitric oxide synthase.
Nature
375:408-411[Medline].
|
| 49.
|
Yoshida, A.,
Y. Koide,
M. Uchijima, and T. O. Yoshida.
1995.
Dissection of strain difference in acquired protective immunity against Mycobacterium bovis Calmette-Guerin bacillus (BCG). Macrophages regulate the susceptibility through cytokine network and the induction of nitric oxide synthase.
J. Immunol.
155:2057-2066[Abstract].
|
Infect Immun, March 1998, p. 1208-1215, Vol. 66, No. 3
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Schreiber, T., Ehlers, S., Heitmann, L., Rausch, A., Mages, J., Murray, P. J., Lang, R., Holscher, C.
(2009). Autocrine IL-10 Induces Hallmarks of Alternative Activation in Macrophages and Suppresses Antituberculosis Effector Mechanisms without Compromising T Cell Immunity. J. Immunol.
183: 1301-1312
[Abstract]
[Full Text]
-
Chessler, A.-D. C., Unnikrishnan, M., Bei, A. K., Daily, J. P., Burleigh, B. A.
(2009). Trypanosoma cruzi Triggers an Early Type I IFN Response In Vivo at the Site of Intradermal Infection. J. Immunol.
182: 2288-2296
[Abstract]
[Full Text]
-
Ny, L., Li, H., Mukherjee, S., Persson, K., Holmqvist, B., Zhao, D., Shtutin, V., Huang, H., Weiss, L. M., Machado, F. S., Factor, S. M., Chan, J., Tanowitz, H. B., Jelicks, L. A.
(2008). A Magnetic Resonance Imaging Study of Intestinal Dilation in Trypanosoma cruzi-infected Mice Deficient in Nitric Oxide Synthase. Am J Trop Med Hyg
79: 760-767
[Abstract]
[Full Text]
-
Garcia, M. M., De Rissio, A. M., Villalonga, X., Mengoni, E., Cardoni, R. L.
(2008). Soluble Tumor Necrosis Factor (TNF) Receptors (sTNF-R1 and -R2) in Pregnant Women Chronically Infected with Trypanosoma cruzi and their Children. Am J Trop Med Hyg
78: 499-503
[Abstract]
[Full Text]
-
Costa, V. M. A., Torres, K. C. L., Mendonca, R. Z., Gresser, I., Gollob, K. J., Abrahamsohn, I. A.
(2006). Type I IFNs Stimulate Nitric Oxide Production and Resistance to Trypanosoma cruzi Infection.. J. Immunol.
177: 3193-3200
[Abstract]
[Full Text]
-
Reyes, J. L., Terrazas, L. I., Espinoza, B., Cruz-Robles, D., Soto, V., Rivera-Montoya, I., Gomez-Garcia, L., Snider, H., Satoskar, A. R., Rodriguez-Sosa, M.
(2006). Macrophage Migration Inhibitory Factor Contributes to Host Defense against Acute Trypanosoma cruzi Infection. Infect. Immun.
74: 3170-3179
[Abstract]
[Full Text]
-
Hardison, J. L., Wrightsman, R. A., Carpenter, P. M., Lane, T. E., Manning, J. E.
(2006). The Chemokines CXCL9 and CXCL10 Promote a Protective Immune Response but Do Not Contribute to Cardiac Inflammation following Infection with Trypanosoma cruzi. Infect. Immun.
74: 125-134
[Abstract]
[Full Text]
-
Hardison, J. L., Wrightsman, R. A., Carpenter, P. M., Kuziel, W. A., Lane, T. E., Manning, J. E.
(2006). The CC Chemokine Receptor 5 Is Important in Control of Parasite Replication and Acute Cardiac Inflammation following Infection with Trypanosoma cruzi. Infect. Immun.
74: 135-143
[Abstract]
[Full Text]
-
Petersen, C. A., Krumholz, K. A., Burleigh, B. A.
(2005). Toll-Like Receptor 2 Regulates Interleukin-1{beta}-Dependent Cardiomyocyte Hypertrophy Triggered by Trypanosoma cruzi. Infect. Immun.
73: 6974-6980
[Abstract]
[Full Text]
-
Hoft, D. F., Eickhoff, C. S.
(2005). Type 1 Immunity Provides Both Optimal Mucosal and Systemic Protection against a Mucosally Invasive, Intracellular Pathogen. Infect. Immun.
73: 4934-4940
[Abstract]
[Full Text]
-
Holscher, C., Holscher, A., Ruckerl, D., Yoshimoto, T., Yoshida, H., Mak, T., Saris, C., Ehlers, S.
(2005). The IL-27 Receptor Chain WSX-1 Differentially Regulates Antibacterial Immunity and Survival during Experimental Tuberculosis. J. Immunol.
174: 3534-3544
[Abstract]
[Full Text]
-
Lieke, T., Graefe, S. E. B., Klauenberg, U., Fleischer, B., Jacobs, T.
(2004). NK Cells Contribute to the Control of Trypanosoma cruzi Infection by Killing Free Parasites by Perforin-Independent Mechanisms. Infect. Immun.
72: 6817-6825
[Abstract]
[Full Text]
-
Ropert, C., Tostes Gazzinelli, R.
(2004). Regulatory role of Toll-like receptor 2 during infection with Trypanosoma cruzi. Innate Immunity
10: 425-430
[Abstract]
-
Cummings, K. L., Tarleton, R. L.
(2004). Inducible Nitric Oxide Synthase Is Not Essential for Control of Trypanosoma cruzi Infection in Mice. Infect. Immun.
72: 4081-4089
[Abstract]
[Full Text]
-
Michailowsky, V., Celes, M. R. N., Marino, A. P., Silva, A. A., Vieira, L. Q., Rossi, M. A., Gazzinelli, R. T., Lannes-Vieira, J., Silva, J. S.
(2004). Intercellular Adhesion Molecule 1 Deficiency Leads to Impaired Recruitment of T Lymphocytes and Enhanced Host Susceptibility to Infection with Trypanosoma cruzi. J. Immunol.
173: 463-470
[Abstract]
[Full Text]
-
Martins, G. A., Tadokoro, C. E., Silva, R. B., Silva, J. S., Rizzo, L. V.
(2004). CTLA-4 Blockage Increases Resistance to Infection with the Intracellular Protozoan Trypanosoma cruzi. J. Immunol.
172: 4893-4901
[Abstract]
[Full Text]
-
Arantes, R. M.E., Marche, H. H.F., Bahia, M. T., Cunha, F. Q., Rossi, M. A., Silva, J. S.
(2004). Interferon-{gamma}-Induced Nitric Oxide Causes Intrinsic Intestinal Denervation in Trypanosoma cruzi-Infected Mice. Am. J. Pathol.
164: 1361-1368
[Abstract]
[Full Text]
-
Saeftel, M., Krueger, A., Arriens, S., Heussler, V., Racz, P., Fleischer, B., Brombacher, F., Hoerauf, A.
(2004). Mice Deficient in Interleukin-4 (IL-4) or IL-4 Receptor {alpha} Have Higher Resistance to Sporozoite Infection with Plasmodium berghei (ANKA) than Do Naive Wild-Type Mice. Infect. Immun.
72: 322-331
[Abstract]
[Full Text]
-
Drennan, M. B., Nicolle, D., Quesniaux, V. J. F., Jacobs, M., Allie, N., Mpagi, J., Fremond, C., Wagner, H., Kirschning, C., Ryffel, B.
(2004). Toll-Like Receptor 2-Deficient Mice Succumb to Mycobacterium tuberculosis Infection. Am. J. Pathol.
164: 49-57
[Abstract]
[Full Text]
-
Boscardin, S. B., Kinoshita, S. S., Fujimura, A. E., Rodrigues, M. M.
(2003). Immunization with cDNA Expressed by Amastigotes of Trypanosoma cruzi Elicits Protective Immune Response against Experimental Infection. Infect. Immun.
71: 2744-2757
[Abstract]
[Full Text]
-
Goni, O., Alcaide, P., Fresno, M.
(2002). Immunosuppression during acute Trypanosoma cruzi infection: involvement of Ly6G (Gr1+)CD11b+ immature myeloid suppressor cells. Int Immunol
14: 1125-1134
[Abstract]
[Full Text]
-
Duthie, M. S., Wleklinski-Lee, M., Smith, S., Nakayama, T., Taniguchi, M., Kahn, S. J.
(2002). During Trypanosoma cruzi Infection CD1d-Restricted NK T Cells Limit Parasitemia and Augment the Antibody Response to a Glycophosphoinositol-Modified Surface Protein. Infect. Immun.
70: 36-48
[Abstract]
[Full Text]
-
Holscher, C., Atkinson, R. A., Arendse, B., Brown, N., Myburgh, E., Alber, G., Brombacher, F.
(2001). A Protective and Agonistic Function of IL-12p40 in Mycobacterial Infection. J. Immunol.
167: 6957-6966
[Abstract]
[Full Text]
-
Michailowsky, V., Silva, N. M., Rocha, C. D., Vieira, L. Q., Lannes-Vieira, J., Gazzinelli, R. T.
(2001). Pivotal Role of Interleukin-12 and Interferon-{gamma} Axis in Controlling Tissue Parasitism and Inflammation in the Heart and Central Nervous System during Trypanosoma cruzi Infection. Am. J. Pathol.
159: 1723-1733
[Abstract]
[Full Text]
-
Muller, U., Kohler, G., Mossmann, H., Schaub, G. A., Alber, G., Di Santo, J. P., Brombacher, F., Holscher, C.
(2001). IL-12-Independent IFN-{gamma} Production by T Cells in Experimental Chagas' Disease Is Mediated by IL-18. J. Immunol.
167: 3346-3353
[Abstract]
[Full Text]
-
Fujimura, A. E., Kinoshita, S. S., Pereira-Chioccola, V. L., Rodrigues, M. M.
(2001). DNA Sequences Encoding CD4+ and CD8+ T-Cell Epitopes Are Important for Efficient Protective Immunity Induced by DNA Vaccination with a Trypanosoma cruzi Gene. Infect. Immun.
69: 5477-5486
[Abstract]
[Full Text]
-
Soares, M. B. P., Silva-Mota, K. N., Lima, R. S., Bellintani, M. C., Pontes-de-Carvalho, L., Ribeiro-dos-Santos, R.
(2001). Modulation of Chagasic Cardiomyopathy by Interleukin-4 : Dissociation between Inflammation and Tissue Parasitism. Am. J. Pathol.
159: 703-709
[Abstract]
[Full Text]
-
Shoda, L. K. M., Kegerreis, K. A., Suarez, C. E., Roditi, I., Corral, R. S., Bertot, G. M., Norimine, J., Brown, W. C.
(2001). DNA from Protozoan Parasites Babesia bovis, Trypanosoma cruzi, and T. brucei Is Mitogenic for B Lymphocytes and Stimulates Macrophage Expression of Interleukin-12, Tumor Necrosis Factor Alpha, and Nitric Oxide. Infect. Immun.
69: 2162-2171
[Abstract]
[Full Text]
-
Saeftel, M., Fleischer, B., Hoerauf, A.
(2001). Stage-Dependent Role of Nitric Oxide in Control of Trypanosoma cruzi Infection. Infect. Immun.
69: 2252-2259
[Abstract]
[Full Text]
-
Tarleton, R. L., Grusby, M. J., Zhang, L.
(2000). Increased Susceptibility of Stat4-Deficient and Enhanced Resistance in Stat6-Deficient Mice to Infection with Trypanosoma cruzi. J. Immunol.
165: 1520-1525
[Abstract]
[Full Text]
-
Holscher, C., Mohrs, M., Dai, W. J., Kohler, G., Ryffel, B., Schaub, G. A., Mossmann, H., Brombacher, F.
(2000). Tumor Necrosis Factor Alpha-Mediated Toxic Shock in Trypanosoma cruzi-Infected Interleukin 10-Deficient Mice. Infect. Immun.
68: 4075-4083
[Abstract]
[Full Text]
-
Banerjee, R., Anguita, J., Fikrig, E.
(2000). Granulocytic Ehrlichiosis in Mice Deficient in Phagocyte Oxidase or Inducible Nitric Oxide Synthase. Infect. Immun.
68: 4361-4362
[Abstract]
[Full Text]
-
Mohrs, M., Holscher, C., Brombacher, F.
(2000). Interleukin-4 Receptor Alpha-Deficient BALB/c Mice Show an Unimpaired T Helper 2 Polarization in Response to Leishmania major Infection. Infect. Immun.
68: 1773-1780
[Abstract]
[Full Text]
-
Hall, B. S., Tam, W., Sen, R., Pereira, M. E. A.
(2000). Cell-specific Activation of Nuclear Factor-kappa B by the Parasite Trypanosoma cruzi Promotes Resistance to Intracellular Infection. Mol. Biol. Cell
11: 153-160
[Abstract]
[Full Text]
-
Rodrigues, M. M., Ribeirao, M., Pereira-Chioccola, V., Renia, L., Costa, F.
(1999). Predominance of CD4 Th1 and CD8 Tc1 Cells Revealed by Characterization of the Cellular Immune Response Generated by Immunization with a DNA Vaccine Containing a Trypanosoma cruzi Gene. Infect. Immun.
67: 3855-3863
[Abstract]
[Full Text]
-
Martins, G. A., Vieira, L. Q., Cunha, F. Q., Silva, J. S.
(1999). Gamma Interferon Modulates CD95 (Fas) and CD95 Ligand (Fas-L) Expression and Nitric Oxide-Induced Apoptosis during the Acute Phase of Trypanosoma cruzi Infection: a Possible Role in Immune Response Control. Infect. Immun.
67: 3864-3871
[Abstract]
[Full Text]
-
Chaussabel, D., Jacobs, F., de Jonge, J., de Veerman, M., Carlier, Y., Thielemans, K., Goldman, M., Vray, B.
(1999). CD40 Ligation Prevents Trypanosoma cruzi Infection through Interleukin-12 Upregulation. Infect. Immun.
67: 1929-1934
[Abstract]
[Full Text]
-
MacFarlane, A. S., Schwacha, M. G., Eisenstein, T. K.
(1999). In Vivo Blockage of Nitric Oxide with Aminoguanidine Inhibits Immunosuppression Induced by an Attenuated Strain of Salmonella typhimurium, Potentiates Salmonella Infection, and Inhibits Macrophage and Polymorphonuclear Leukocyte Influx into the Spleen. Infect. Immun.
67: 891-898
[Abstract]
[Full Text]
-
Villalta, F., Zhang, Y., Bibb, K. E., Kappes, J. C., Lima, M. F.
(1998). The Cysteine-Cysteine Family of Chemokines RANTES, MIP-1alpha , and MIP-1beta Induce Trypanocidal Activity in Human Macrophages via Nitric Oxide. Infect. Immun.
66: 4690-4695
[Abstract]
[Full Text]